Newer antifungal agents for fungal infection prevention during hematopoietic cell transplantation: A meta-analysis

Transplantation Proceedings

Volumn 45, Issue 1, 2013, Pages 407-414

  Xu, S X ^a   Shen, J L ^a   Tang, X F ^a   Feng, B ^a  

^a NAVY GENERAL HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; CASPOFUNGIN; ECHINOCANDIN; FLUCONAZOLE; ITRACONAZOLE; MICAFUNGIN; POSACONAZOLE; TRIAZOLE DERIVATIVE; VORICONAZOLE;

ARTICLE; COMPARATIVE EFFECTIVENESS; CONTROLLED CLINICAL TRIAL (TOPIC); DIARRHEA; DRUG EFFICACY; DRUG TOLERABILITY; DRUG WITHDRAWAL; GASTROINTESTINAL SYMPTOM; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HYPOKALEMIA; INCIDENCE; INFECTION PREVENTION; KIDNEY DYSFUNCTION; LIVER DYSFUNCTION; META ANALYSIS; MYCOSIS; NAUSEA AND VOMITING; NEPHROTOXICITY; PRIORITY JOURNAL; SURGICAL MORTALITY;

ANTIFUNGAL AGENTS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MYCOSES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME; TRIAZOLES;

EID: 84873284787     PISSN: 00411345     EISSN: 18732623     Source Type: Journal    
DOI: 10.1016/j.transproceed.2012.07.149     Document Type: Article

References (43)

1. J.W. Baddley, D.R. Andes, K.A. Marr Factors associated with mortality in transplant patients with invasive aspergillosis Clin Infect Dis 50 2010 1559 1567
2. N.S. Hamza, M.A. Ghannoum, H.M. Lazarus Antifungal prophylaxis in hematopoietic stem cell transplant recipients Bone Marrow Transplant 34 2004 377 389
3. H.L. Leather, J.R. Wingard Infections following hematopoietic stem cell transplantation Infect Dis Clin North Am 15 2001 483 520
4. J.L. Goodman, D.J. Winston, R.A. Greenfield A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation N Engl J Med 326 1992 845 851
5. J. El-Cheikh, C. Faucher, S. Fürst High-dose weekly liposomal amphotericin B antifungal prophylaxis following reduced-intensity conditioning allogeneic stem cell transplantation Bone Marrow Transplantation 39 2007 301 306
6. D.J. Winston, R.T. Maziarz, P.H. Chandrasekar Intravenous and oral itraconazole versus intravenous and oral fluconazole for long-term antifungal prophylaxis in allogeneic hematopoietic stem-cell transplant recipients A multicenter, randomized trial Ann Intern Med 138 2003 705 713
7. A. Glasmacher, A. Prentice, M. Gorschlüter Itraconazole prevents invasive fungal infections in neutropenic patients treated for hematologic malignancies: evidence from a meta-analysis of 3,597 patients J Clin Oncol 21 2003 4615 4626
8. G.R. Morgenstern, A.G. Prentice, H.G. Prentice A randomized controlled trial of itraconazole versus fluconazole for the prevention of fungal infections in patients with haematological malignancies U.K. Multicentre Antifungal Prophylaxis Study Group Br J Haematol 105 1999 901 911
9. K.A. Marr, F. Crippa, W. Leisenring Itraconazole versus fluconazole for prevention of fungal infections in patients receiving allogeneic stem cell transplants Blood 103 2004 1527 1533
10. R. Herbrecht, D.W. Denning, T.F. Patterson Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis N Engl J Med 347 2002 408 415
11. J. Onishi, M. Meinz, J. Thompson Discovery of novel antifungal (1,3)-betad-glucan synthase inhibitors Antimicrob Chemother 44 1999 368 377
12. M. Egger, G. Davey Smith Bias in meta-analysis detected by a simple, graphical test BMI 315 1997 629 634
13. S. Duval, R. Tweedie Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis Biometrics 56 2000 455 463
14. A.C. Reboli, C. Rotstein, P.G. Pappas Anidulafungin Study Group Anidulafungin versus fluconazole for invasive candidiasis N Engl J Med 356 2007 2472 2482
15. Y. Hirata, T. Yokote, K. Kobayashi Antifungal prophylaxis with micafungin in neutropenic patients with hematological malignancies Leuk Lymphoma 51 2010 853 859
16. S. Hashino, L. Morita, M. Takahata Administration of micafungin as prophylactic antifungal therapy in patients undergoing allogeneic stem cell transplantation Int J Hematol 87 2008 91 97
17. Y. Hiramatsu, Y. Maeda, N. Fujii Use of micafungin versus fluconazole for antifungal prophylaxis in neutropenic patients receiving hematopoietic stem cell transplantation Int J Hematol 88 2008 588 595
18. J.A. van Burik, V. Ratanatharathorn, D.E. Stepan Micafungin versus fluconazole for prophylaxis against invasive fungal infections during neutropenia in patients undergoing hematopoietic stem cell transplantation Clin Infect Dis 39 2004 1407 1416
19. A. Riedel, L. Choe, J. Inciardi Antifungal prophylaxis in chemotherapy-associated neutropenia: a retrospective, observational study BMC Infect Dis 7 2007 70
20. J. Hiemenz, P. Cagnoni, D. Simpson Pharmacokinetic and maximum tolerated dose study of micafungin in combination with fluconazole versus fluconazole alone for prophylaxis of fungal infections in adult patients undergoing a bone marrow or peripheral stem cell transplant Antimicrob Agents Chemother 49 2005 1331 1336
21. J.R. Wingard, S.L. Carter, T.J. Walsh Randomized, double-blind trial of fluconazole versus voriconazole for prevention of invasive fungal infection after allogeneic hematopoietic cell transplantation Blood 116 2010 5111 5118
22. U. Gergis, K. Markey, J. Greene Voriconazole provides effective prophylaxis for invasive fungal infection in patients receiving glucocorticoid therapy for GVHD Bone Marrow Transplant 45 2010 662 667
23. D.I. Marks, A. Pagliuca, C.C. Kibbler Voriconazole versus itraconazole for antifungal prophylaxis following allogeneic haematopoietic stem-cell transplantation Br J Haematol 155 2011 318 327
24. R. de la Cámara, I. Jarque, M.A. Sanz Economic evaluation of posaconazole vs fluconazole in the prevention of invasive fungal infections in patients with GVHD following haematopoietic SCT Bone Marrow Transplant 45 2010 925 932
25. I. Sánchez-Ortega, B. Patiño, M. Arnan Clinical efficacy and safety of primary antifungal prophylaxis with posaconazole vs itraconazole in allogeneic blood and marrow transplantation Bone Marrow Transplant 46 2010 733 739
26. O.A. Cornely, J. Maertens, D.J. Winston Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia N Engl J Med 356 2007 348 359
27. J. Hahn, F. Stifel, A. Reichle Clinical experience with posaconazole prophylaxis-a retrospective analysis in a haematological unit Mycoses 54 Suppl 1 2011 12 16
28. G.N. Mattiuzzi, G. Alvarado, F.J. Giles Open-label, randomized comparison of itraconazole versus caspofungin for prophylaxis in patients with hematologic malignancies Antimicrob Agents Chemother 50 2006 143 147
29. M. Ellis, C. Frampton, J. Joseph An open study of the comparative efficacy and safety of caspofungin and liposomal amphotericin B in treating invasive fungal infections or febrile neutropenia in patients with haematological malignancy J Med Microbiol 55 2006 1357 1365
30. D.W. Kubiak, J.M. Bryar, A.M. McDonnell Evaluation of caspofungin or micafungin as empiric antifungal therapy in adult patients with persistent febrile neutropenia: a retrospective, observational, sequential cohort analysis Clin Ther 32 2010 637 648
31. C.T. Rieger, H. Ostermann, H.J. Kolb A clinical cohort trial of antifungal combination therapy: efficacy and toxicity in haematological cancer patients Ann Hematol 87 2008 915 922
32. A. Finckh, M.R. Tramer Primer: strengths and weaknesses of meta-analysis Nat Clin Pract Rheumatol 4 2008 146 152
33. M.A. Slavin, B. Osborne, R. Adams Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation - a prospective randomized double blind study J infect Dis 171 1995 1545 1552
34. K.A. Marr, K. Seidel, M.A. Slavin Prolonged fluconazole prophylaxis is associated with persistent protection against candidiasis-related death in allogeneic marrow transplant recipients: long-term follow-up of a randomized, placebo-controlled trial Blood 96 2000 2055 2061
35. R. Nau, F. Sörgel, H. Eiffert Penetration of drugs through the blood-cerebrospinal fluid/blood-brain barrier for treatment of central nervous system infections Clin Microbiol Rev 23 2010 858 883
36. D.J. Winston, R.T. Maziarz, P.H. Chandrasekar Intravenous and oral itraconazole versus intravenous and oral fluconazole for long-term antifungal prophylaxis in allogeneic hematopoietic stem-cell transplant recipients A multicenter, randomized trial Ann Intern Med 138 2003 705 713
37. A.K. O'Sullivan, A. Pandya, G. Papadopoulos Cost-effectiveness of posaconazole versus fluconazole or itraconazole in the prevention of invasive fungal infections among neutropenic patients in the United States Value Health 12 2009 666 673
38. A.K. O'Sullivan, M.C. Weinstein, A. Pandya et al. Cost effectiveness of posaconazole vs fluconazole in the prevention of invasive fungal infections among patients with graft-versus host disease (GVHD) in the U.S. [abstract] Blood 110 2007 abstract 3336
39. S.C. Chen, M.A. Slavin, T.C. Sorrell Echinocandin antifungal drugs in fungal infections: a comparison Drugs 71 2011 11 41
40. R. Herbrecht, Y. Nivoix, C. Fohrer Management of systemic fungal infections: alternatives to itraconazole J Antimicrob Chemother 56 Suppl 1 2005 i39 i48
41. M. Yanada, H. Kiyoi, M. Murata Micafungin, a novel antifungal agent, as empirical therapy in acute leukemia patients with febrile neutropenia Intern Med 45 2006 259 264
42. T.J. Walsh, H. Teppler, G.R. Donowitz Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia N Engl J Med 351 2004 1391 1402
43. R. Martino, C. Viscoli Empirical antifungal therapy in patients with neutropenia and persistent or recurrent fever of unknown origin Br J Haematol 132 2006 138 154